Insider · CIK 0001798929
Jacqueline Zummo
officer
Files at TARA (Protara Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -3,724 | $6.67 | $25k | 118,559 | Jan 27, 2026 |
| Jan 20, 2026 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -6,578 | $5.60 | $37k | 122,283 | Jan 22, 2026 |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc. | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 128,861 | Jan 21, 2026 |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +180,000 | $0.00 | $0 | 180,000 | Jan 21, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.